Format

Send to

Choose Destination
Thorac Surg Clin. 2014 Feb;24(1):117-127. doi: 10.1016/j.thorsurg.2013.09.006. Epub 2013 Nov 9.

Treatment of malignant tracheoesophageal fistula.

Author information

1
Thoracic Surgery Department, Catholic Clinics Koblenz-Montabaur, University Teaching Hospital, R. Virchow Street 7, 56073 Koblenz, Germany.
2
Radiology Department, Catholic Clinics Koblenz-Montabaur, University Teaching Hospital, R. Virchow Street 7, 56073 Koblenz, Germany. Electronic address: s.herber@kk-km.de.

Abstract

This article addresses the treatment of malignant enterorespiratory fistulas, especially malignant tracheoesophageal fistula (mTEF). mTEF typically occurs after radiochemotherapy for advanced esophageal cancer. Life expectancy is measured in months after successful treatment, and in days to weeks with a persistent fistula. To stop repeated episodes of aspiration and septic pneumonia, single or double stenting of the esophagus and trachea with self-expandable coated stents is the established palliative treatment. The indications, techniques, and pitfalls of esophageal and tracheal stenting are described. Surgical interventions are justified only in very select cases, so this article focuses on interventional rather than surgical treatment.

KEYWORDS:

Endobronchial stenting; Endoesophageal stenting; Enterorespiratory fistula; Interventional bronchoscopy; Interventional esophagoscopy; Interventional radiology; Tracheoesophageal fistula

PMID:
24295667
DOI:
10.1016/j.thorsurg.2013.09.006
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center